Recent Finacing
Recent Raise
Nkure develops allogeneic NK and CAR‑NK cell therapies for hematologic and solid tumors, with lab‑scale NK platform, CAR licenses, partners India and US CDMOs, and advances IND‑enabling studies.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at NKure Therapeutics.
